Assignee
TERSERA THERAPEUTICS LLC
US·3 granted patents·5 pending applications·36 citations·filing 2017–2024
Top patents by PatentIndex Score
8 records- 0197US10307463B2Method for administering omega-conopeptideTERSERA THERAPEUTICS LLC·Filed 2017·Granted Jun 4, 2019·36 cites·9 claims
- 0279US10857204B2Method for administering omega-conopeptideTERSERA THERAPEUTICS LLC·Filed 2019·Granted Dec 8, 2020·0 cites·10 claims
- 0369US11406635B2Solid dosage forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoateTERSERA THERAPEUTICS LLC·Filed 2019·Granted Aug 9, 2022·0 cites·1 claims
- 0464US2025367261A1Goserelin implant dosing regimens for improved patient complianceTERSERA THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0564US2026014149A1Methods of treating merkel cell carcinoma with tryptophan hydoxylase inhibitorsTERSERA THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0662US2025367252A1Goserelin implant dosing regimens for improved patient complianceTERSERA THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0758US2023310434A1Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumorsTERSERA THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 0848US2021353624A1Method of treating cancer with telotrisat or a prodrug thereofTERSERA THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →